2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine
C112H117F6N25Pt4 — CID 158421616
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine
2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine (PubChem CID 158421616) has the molecular formula C112H117F6N25Pt4 and a molecular weight of 2707.64 g/mol. Its IUPAC name is 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine.
Molecular Properties
| Compound Name | 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine |
|---|---|
| PubChem CID | 158421616 |
| Molecular Formula | C112H117F6N25Pt4 |
| Molecular Weight | 2707.64 g/mol |
| Exact Mass | 2705.84 |
| IUPAC Name | 2,6-bis(3-tert-butylpyrazol-1-id-5-yl)-4-(3,5-ditert-butylphenyl)pyridine;3,5-bis(1-methylimidazol-2-yl)-4H-pyridin-4-ide;2,6-bis[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;3-(3-tert-butylpyrazol-1-id-5-yl)-1-(7,7-dimethyl-5,6-dihydro-4H-indazol-2-id-3-yl)isoquinoline;4-tert-butylpyridine;isoquinoline;methylbenzene;tetrakis(platinum(2+));pyridine |
| SMILES | CC(C)(C)c1cc(-c2cc(-c3cc(C(C)(C)C)n[n-]3)nc(-c3cc(C(C)(C)C)n[n-]3)c2)cc(C(C)(C)C)c1.CC(C)(C)c1cc(-c2cc3ccccc3c(-c3[n-]nc4c3CCCC4(C)C)n2)[n-]n1.CC(C)(C)c1ccncc1.Cc1cc[c-]cc1.Cn1ccnc1-c1[c-]c(-c2nccn2C)cnc1.FC(F)(F)c1n[n-]c(-c2cccc(-c3nc(C(F)(F)F)n[n-]3)n2)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].c1ccc2cnccc2c1.c1ccncc1 |
| InChI | InChI=1S/C33H43N5.C25H27N5.C13H12N5.C11H3F6N7.C9H7N.C9H13N.C7H7.C5H5N.4Pt/c1-30(2,3)22-13-20(14-23(17-22)31(4,5)6)21-15-24(26-18-28(37-35-26)32(7,8)9)34-25(16-21)27-19-29(38-36-27)33(10,11)12;1-24(2,3)20-14-19(27-28-20)18-13-15-9-6-7-10-16(15)21(26-18)22-17-11-8-12-25(4,5)23(17)30-29-22;1-17-5-3-15-12(17)10-7-11(9-14-8-10)13-16-4-6-18(13)2;12-10(13,14)8-19-6(21-23-8)4-2-1-3-5(18-4)7-20-9(24-22-7)11(15,16)17;1-2-4-9-7-10-6-5-8(9)3-1;1-9(2,3)8-4-6-10-7-5-8;1-7-5-3-2-4-6-7;1-2-4-6-5-3-1;;;;/h13-19H,1-12H3;6-7,9-10,13-14H,8,11-12H2,1-5H3;3-6,8-9H,1-2H3;1-3H;1-7H;4-7H,1-3H3;3-6H,1H3;1-5H;;;;/q2*-2;-1;-2;;;-1;;4*+2 |
| InChIKey | FUPJULDKXFULPX-UHFFFAOYSA-N |
| XLogP | 24.27 |
| TPSA | 313.59 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 19 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 147 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2707.64 |
| LogP ≤ 5 | 24.27 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 19 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158421616 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.